BALB/c 마우스에서 발효 홍삼 Ginsenoside의 생체이용율과 항염효과 = Bioavailability and Anti-inflammatory Effect of Fermented Red Ginseng in BALB/c Mouse

다국어 초록 (Multilingual Abstract)

The fermented red ginseng by microorganism is known to increase pharmacological activity in vivo. To evaluate the bioavailablity of red ginseng fermented by probiotics, we conducted the pharmacokinetic study of ginsenoside Rb1, Rd and total ginsenosides (TG, ginsenosides Rb1 + Rd + Rg1 + F2 + Rg3 + compound K) in BALB/C mice. The AUC value of ginsenoside Rb1 in mice serum administered with 600㎎/㎏ drugs showed 21.93 ± 14.68 ng·h/mL (RGw, water extract), 275.211 ± 110.04 ng·h/mL (RGe, 50% ethanol extract) and 404.91 ± 162.57 ng·h/mL (fRGe, fermented red ginseng extract). Analysis of ginsenoside Rd also showed a higher ACU value in fRGe than in RGw or RGe. And the AUC value of total ginsenosides in mice serum treated with 600 ㎎/㎏ were observed 42.12 ± 23.44 ng·h/mL (RGw), 321.44 ± 133.5 ng·h/mL (RGe) and 537.33 ± 229.01 ng·h/mL (fRGe), respectively. Cmax value of ginsenoside Rb1 in mice administered with 600㎎/㎏ were observed 3.67 ± 3.34 ng/mL (RGw), 23.27 ± 8.81 ng/mL (RGe) and 25.52 ± 7.29 ng/mL (fRGe). These results can be considered that the fermented red ginseng has more bioavailability than that of unfermented red ginseng. In quantitative analysis of the inflammation-related cytokines IL-1β and TNF, no significant difference was found between the fermented red ginseng (fRGe) and the red ginseng (RGe).

목차 (Table of Contents)

• 서 언 재료 및 방법 결과 고 찰 적요 Conflicts of Interest References

참고문헌 (Reference)

1 李翔国, "홍삼 물 추출액의 사포닌 함량 및 맛의 증진을 위한 추출 조건" 한국작물학회 54 (54): 287-293, 2009

2 김수철, "추출용매에 따른 산양삼의 진세노사이드(Rg1, Rb1) 함량과 radical-scavenging 활성 비교" 한국식품저장유통학회 28 (28): 261-269, 2021

3 이강선, "추출방법에 따른 홍삼추출액의 사포닌 조성과 품질특성" 한국약용작물학회 21 (21): 276-281, 2013

4 고성권, "백삼 및 홍삼 농축액의 사포닌 분석" 한국식품과학회 35 (35): 536-539, 2003

5 최지원, "기호성 개선 인삼농축액 제조를 위한 추출 조건 설정" 한국식품저장유통학회 23 (23): 319-325, 2016

6 심건섭, "β-Glucosidase 생산 유산균주의 분리와 이를 이용한 팽화홍삼 추출액의 생물전환" 한국산업식품공학회 18 (18): 332-340, 2014

7 Choi, J. H., "Variation of ginseng extract by heat treatment" 24 (24): 50-58, 1981

8 Park, H., "The role of gut microbiota in ginsenoside metabolism and biotransformatino of ginsenoside by lactic acid bacteria" 5 (5): 1-12, 2019

9 Nam, K.Y, "The main ingreadients and efficacy of Koryeo red ginseng" 16 (16): 33-39, 2009

10 김지혜, "Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases" 고려인삼학회 41 (41): 435-443, 2017

11 Xiaoyan Zhang, "Prebiotics enhance the biotransformation and bioavailability of ginsenosides in rats by modulating gut microbiota" 고려인삼학회 45 (45): 334-343, 2021

12 Hasegawa, H., "Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters" 23 (23): 298-304, 2000

13 Trinh, H.T., "Intestinal microflora enhance the anti-pruritic activities of several glycosides from herbal medicines" Kyeonghee Univ. 2011

14 Akao, T., "Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng" 50 : 1155-1160, 1998

15 Wakabayashi, C., "In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration" 9 : 411-417, 1997

16 Cho, J. Y, "Immuno-regulatory efficacy or red ginseng derived ingredients" 6-12, 2009

17 U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, "Guidance for industry estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers"

18 Hye In Kim, "Fermented red ginseng and ginsenoside Rd alleviate ovalbumininduced allergic rhinitis in mice by suppressing IgE, interleukin-4, and interleukin-5 expression" 고려인삼학회 43 (43): 635-644, 2019

19 Kim, J. K., "Fermented red ginseng alleviates cyclophosphamide-induced immunosuppression and 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice by regulation macrophage activation and T cell differentiation" 48 (48): 1879-1897, 2018

20 Choi, S. Y., "Fermented Korean red ginseng extract enriched in Rd and Rg3 protects against non-alcoholic fatty liver disease through regulation of mTORC1" 11 : 2963-, 2019

21 Jeon-Kyung Kim, "Effects of gut microbiota on the pharmacokinetics of protopanaxadiol ginsenosides Rd, Rg3, F2, and compound K in healthy volunteers treated orally with red ginseng" 고려인삼학회 44 (44): 611-618, 2020

22 So Jin Lee, "Changes in the ginsenoside content during the fermentation process using microbial strains" 고려인삼학회 39 (39): 392-397, 2015

23 Ahn, N.G., "Changes in chemical composition during red ginseng manufacturing process" Kongju National Univ. 2015

24 Saba, E., "Anti-inflammatory activity of Rg3-enriched Korean red ginseng extract in murine model of sepsis" 2018 : 6874692-, 2018

25 Youl Her, "An Application of β-glycosidase to Transformation of Ginsenosides for the Effective Production of Specific Ginsenosides with Biological Efficacy" 한국생물공학회 17 (17): 538-546, 2012

26 김경아, "A prebiotic fiber increases the formation and subsequent absorption of compound K following oral administration of ginseng in rats" 고려인삼학회 39 (39): 183-187, 2015